generics
$7 a month for all eligible generics
Amazon has announced a new service whereby its Prime members can get all of their eligible generic medicines for a small fee – including delivery Pulmonologist and chief medical officer …
Is compromised lamotrigine being distributed in Australia?
Faulty batches of generic lamotrigine tablets are being dispensed to patients in Australia, a new study claims, following two adverse reactions Two patients experienced side effects after taking a generic …
The Generic
No question has divided more patients, pharmacists and doctors in recent times than “Do you want the generic?”, writes Angelo Pricolo The question has intensified, as more expired patents have …
‘If nothing changes then nothing changes.’
Pharmacists report the worst shortages they can recall, as an AMA head suggests stockpiling of critical drugs and a return to Australian manufacturing Patients are being slammed by the cost …
Unauthorised generic substitutions, changes warning
Some pharmacists feel that they can make generic substitutions or changes to instructions where this is unauthorised, thinking these actions have no consequence – but that’s not the case In …
Generics merger gets the go-ahead
The ACCC has announced that it will not oppose the merger of generics companies Arrow and Apotex Once combined, the two companies would supply around half the market for generic …
What’s the real difference between brand vs generic drugs?
Researchers have found public perception bias may lead to more frequent reporting of adverse events for generics A US study has explored whether adverse event reporting patterns are similar between …
Patents extended under revived TPP?
The ACTU has attacked the government over the revived TPP, claiming it would drive up drug prices ACTU president Ged Kearney says that the Trans Pacific Partnership, which is set …
Time for costly medicine monopolies to go from TPP trade talks
Time for costly medicine monopolies to go from TPP trade talks Belinda Townsend, Australian National University; Deborah Gleeson, La Trobe University; Hazel Moir, Australian National University; Joel Lexchin, University of …
King Review option treats pharmacy like ‘utility company’
Several options in the King Review Interim Report, if ever implemented, could put community pharmacy at risk, says the Guild The Guild says that from the time of the Review’s …
Generics pushed, brand prices slashed
A plan to push GPs to prescribe generics has been flagged ahead of the Federal Budget On the ABC’s 7.30 program Monday, reporter Andrew Probyn investigated possible changes to prescribing …
Hospital pharmacists welcome price disclosure recommendations
The SHPA has welcomed the Grattan Institute report’s recommendations on price disclosure The Institute’s conclusion that Australian Government policies have not gone far enough or fast enough to reduce the …